Journal article
Atypical Neuroleptic Malignant Syndrome (NMS) with an Atypical Neuroleptic Clozapine-induced NMS without Rigidity
Annals of clinical psychiatry, Vol.2(4), pp.251-253
1990
DOI: 10.3109/10401239009147953
Abstract
Abstract
Clozapine has been recently FDA approved and is expected to become very popular because of its efficacy and lack of extrapyramidal side effects. The neuroleptic malignant syndrome (NMS) has already been reported in two cases associated with clozapine use. In this article, we present a case in which a patient receiving clozapine monotherapy developed a complex of symptoms that appeared to be NMS without rigidity. The case meets specific criteria for NMS and the absence of rigidity may be attributable to the anatomic selectivity of clozapine's dopamine blockade.
Details
- Title: Subtitle
- Atypical Neuroleptic Malignant Syndrome (NMS) with an Atypical Neuroleptic Clozapine-induced NMS without Rigidity
- Creators
- Peg Nopoulos - The Department of Psychiatry, University of Iowa College of Medicine, Iowa City, IowaMichael Flaum - The Department of Psychiatry, University of Iowa College of Medicine, Iowa City, IowaDel D Miller - The Department of Psychiatry, University of Iowa College of Medicine, Iowa City, Iowa
- Resource Type
- Journal article
- Publication Details
- Annals of clinical psychiatry, Vol.2(4), pp.251-253
- Publisher
- Informa UK Ltd
- DOI
- 10.3109/10401239009147953
- ISSN
- 1040-1237
- eISSN
- 1547-3325
- Language
- English
- Date published
- 1990
- Academic Unit
- Iowa Neuroscience Institute; Neurology; Stead Family Department of Pediatrics; Psychiatry
- Record Identifier
- 9984070650402771
Metrics
22 Record Views